- Home
- TCBP vs PRSO Comparison
TCBP vs PRSO Comparison
Compare TCBP & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- PRSO
- Stock Information
- Founded
- TCBP 2013
- PRSO 2008
- Country
- TCBP United Kingdom
- PRSO United States
- Employees
- TCBP N/A
- PRSO N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- PRSO Semiconductors
- Sector
- TCBP Health Care
- PRSO Technology
- Exchange
- TCBP Nasdaq
- PRSO Nasdaq
- Market Cap
- TCBP 831.0K
- PRSO 3.3M
- IPO Year
- TCBP 2022
- PRSO 2001
- Fundamental
- Price
- TCBP $1.69
- PRSO $0.70
- Analyst Decision
- TCBP Strong Buy
- PRSO Strong Buy
- Analyst Count
- TCBP 1
- PRSO 2
- Target Price
- TCBP $48.00
- PRSO $3.38
- AVG Volume (30 Days)
- TCBP 632.6K
- PRSO 55.6K
- Earning Date
- TCBP 11-25-2024
- PRSO 05-12-2025
- Dividend Yield
- TCBP N/A
- PRSO N/A
- EPS Growth
- TCBP N/A
- PRSO N/A
- EPS
- TCBP N/A
- PRSO N/A
- Revenue
- TCBP N/A
- PRSO $12,728,000.00
- Revenue This Year
- TCBP N/A
- PRSO $9.59
- Revenue Next Year
- TCBP N/A
- PRSO $1.63
- P/E Ratio
- TCBP N/A
- PRSO N/A
- Revenue Growth
- TCBP N/A
- PRSO N/A
- 52 Week Low
- TCBP $1.43
- PRSO $0.69
- 52 Week High
- TCBP $523.20
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- TCBP 28.01
- PRSO 34.62
- Support Level
- TCBP $1.43
- PRSO $0.74
- Resistance Level
- TCBP $2.19
- PRSO $0.87
- Average True Range (ATR)
- TCBP 0.28
- PRSO 0.07
- MACD
- TCBP 0.19
- PRSO -0.01
- Stochastic Oscillator
- TCBP 20.57
- PRSO 4.77
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.